Finance

Lists
Why is NAGE down 2,77%?
Dive Deeper
NAGE:NASDAQ
Niagen Bioscience Inc
2,62 USD
-2,77%
(-0,074) 1D
12-окт., 10:08:22 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
2,67 USD
High
2,68 USD
Low
2,62 USD
Mkt. cap
208,60 млн
Avg. vol.
479,81 миң
Volume
116,14 миң
52-wk high
7,95 USD
52-wk low
2,61 USD
Beta
2,02
Shares outstanding
79,13 млн
No. of employees
117
Open
2,67 USD
High
2,68 USD
Low
2,62 USD
Mkt. cap
208,60 млн
Avg. vol.
479,81 миң
Volume
116,14 миң
52-wk high
7,95 USD
52-wk low
2,61 USD
Beta
2,02
Shares outstanding
79,13 млн
No. of employees
117
News stories
From web sources and news partners
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
HeadquartersЛос Анджелес, Калифорния, Америка Кошмо Штаттары
SectorPersonal care products
Analyst ratings
Based on 4 analysts giving stock ratings to NAGE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NAGE in the last 3 months.
Highest
Current 2,62 USD
11,00 USD (+320,55%)
Average
10,50 USD (+301,44%)
Lowest
10,00 USD (+282,32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean McGowan
Roth MKM
Buy
Maintained
10,00 USD
+282,3%
10/12/2026
Susan Anderson
Canaccord Genuity
Buy
Reiterated
10,00 USD
+282,3%
10/05/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
11,00 USD
+320,6%
08/05/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
11,00 USD
+320,6%
07/21/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
9,00 USD
+244,1%
07/06/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
12,00 USD
+358,8%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
33,99 млн
33,84 млн
31,47 млн
29,78 млн
Cost of goods sold
12,06 млн
12,14 млн
11,50 млн
10,47 млн
Cost of revenue
12,06 млн
12,14 млн
11,50 млн
10,47 млн
Research and development expenses
1,80 млн
1,71 млн
1,48 млн
1,51 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,90 млн
17,89 млн
16,92 млн
17,10 млн
Operating expense
17,69 млн
19,60 млн
18,40 млн
18,61 млн
Total operating expenses
29,75 млн
31,74 млн
29,90 млн
29,08 млн
Operating income
4,24 млн
2,10 млн
1,58 млн
700,00 миң
Other non operating income
-
-214,00 миң
-
-
EBT including unusual items
4,80 млн
4,42 млн
6,74 млн
1,07 млн
EBT excluding unusual items
4,80 млн
2,44 млн
1,95 млн
1,07 млн
Income tax expense
222,00 миң
292,00 миң
417,00 миң
106,00 миң
Effective tax rate
4,62%
6,60%
6,19%
9,92%
Other operating expenses
-
-
-
-
Net income
4,58 млн
4,13 млн
6,32 млн
963,00 миң
Net profit margin
13,47%
12,21%
20,07%
3,23%
Earnings per share
0,05
0,03
0,02
0,01
Interest and investment income
564,00 миң
552,00 миң
375,00 миң
372,00 миң
Interest expense
-
-
-
-
Net interest expenses
564,00 миң
552,00 миң
375,00 миң
372,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
4,43 млн
2,30 млн
1,87 млн
991,00 миң
Gain or loss from assets sale
-
-
-4,78 млн
26,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору